IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity (original) (raw)

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003–1018 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  2. Di Santo, J. P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257–286 (2006)
    Article CAS PubMed Google Scholar
  3. Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44–49 (2011)
    Article ADS CAS PubMed PubMed Central Google Scholar
  4. Bellora, F. et al. Human NK cells and NK receptors. Immunol. Lett. 161, 168–173 (2014)
    Article CAS PubMed Google Scholar
  5. Guillerey, C., Huntington, N. D. & Smyth, M. J. Targeting natural killer cells in cancer immunotherapy. Nat. Immunol. 17, 1025–1036 (2016)
    Article CAS PubMed Google Scholar
  6. Stojanovic, A. & Cerwenka, A. Natural killer cells and solid tumors. J. Innate Immun. 3, 355–364 (2011)
    Article PubMed Google Scholar
  7. Gismondi, A., Stabile, H., Nisti, P. & Santoni, A. Effector functions of natural killer cell subsets in the control of hematological malignancies. Front. Immunol. 6, 567 (2015)
    Article PubMed PubMed Central Google Scholar
  8. Gulen, M. F. et al. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32, 54–66 (2010)
    Article CAS PubMed PubMed Central Google Scholar
  9. Nold-Petry, C. A. et al. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16, 354–365 (2015)
    Article CAS PubMed Google Scholar
  10. Garlanda, C., Riva, F., Bonavita, E. & Mantovani, A. Negative regulatory receptors of the IL-1 family. Semin. Immunol. 25, 408–415 (2013)
    Article CAS PubMed Google Scholar
  11. Cooper, M. A. et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 97, 3146–3151 (2001)
    Article CAS PubMed Google Scholar
  12. Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488–5496 (2009)
    Article CAS PubMed Google Scholar
  13. Kim, S. et al. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3, 523–528 (2002)
    Article PubMed Google Scholar
  14. Takeda, K. et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383–390 (1998)
    Article CAS PubMed Google Scholar
  15. Ganal, S. C. et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 37, 171–186 (2012)
    Article CAS PubMed Google Scholar
  16. Gong, J. et al. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J. Struct. Biol. 169, 323–330 (2010)
    Article CAS PubMed Google Scholar
  17. Marçais, A. et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749–757 (2014)
    Article PubMed PubMed Central Google Scholar
  18. Li, C. et al. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc. Natl Acad. Sci. USA 105, 3017–3022 (2008)
    Article ADS CAS PubMed PubMed Central Google Scholar
  19. Peng, H. & Tian, Z. Re-examining the origin and function of liver-resident NK cells. Trends Immunol. 36, 293–299 (2015)
    Article CAS PubMed Google Scholar
  20. Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007)
    Article ADS CAS PubMed Google Scholar
  21. Dupaul-Chicoine, J. et al. The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity 43, 751–763 (2015)
    Article CAS PubMed Google Scholar
  22. Lisnic´, B., Lisnic´, V. J. & Jonjic´, S. NK cell interplay with cytomegaloviruses. Curr. Opin. Virol. 15, 9–18 (2015)
    Article PubMed Google Scholar
  23. Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. Innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015)
    Article PubMed PubMed Central Google Scholar
  24. Shih, H. Y. et al. Developmental acquisition of regulomes underlies innate lymphoid cell functionality. Cell 165, 1120–1133 (2016)
    Article CAS PubMed PubMed Central Google Scholar
  25. Bellora, F. et al. M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages. Eur. J. Immunol. 42, 1618–1626 (2012)
    Article CAS PubMed Google Scholar
  26. Martín-Fontecha, A. et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5, 1260–1265 (2004)
    Article PubMed Google Scholar
  27. Garlanda, C. et al. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67, 6017–6021 (2007)
    Article CAS PubMed Google Scholar
  28. Xiao, H. et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461–475 (2007)
    Article CAS PubMed Google Scholar
  29. Morvan, M. G. & Lanier, L. L. NK cells and cancer: you can teach innate cells new tricks. Nat. Rev. Cancer 16, 7–19 (2016)
    Article CAS PubMed Google Scholar
  30. He, G. & Karin, M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res. 21, 159–168 (2011)
    Article CAS PubMed Google Scholar
  31. Garlanda, C. et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl Acad. Sci. USA 101, 3522–3526 (2004)
    Article ADS CAS PubMed PubMed Central Google Scholar
  32. Bushnell, B. Bbmap: a fast, accurate, splice-aware aligner (Ernest Orlando Lawrence Berkeley National Laboratory, 2014)
  33. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, http://dx.doi.org/10.14806/ej.17.1.200 (2011)
  34. Dobin, A . et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013)
    Article CAS PubMed Google Scholar
  35. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004)
    Article PubMed PubMed Central Google Scholar
  36. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010)
    CAS PubMed Google Scholar
  37. Majewski, I. J. et al. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 116, 731–739 (2010)
    Article CAS PubMed Google Scholar
  38. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015)
    Article PubMed PubMed Central Google Scholar
  39. Mingozzi, F. et al. Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors. EMBO Mol. Med. 8, 1039–1051 (2016)
    Article CAS PubMed PubMed Central Google Scholar
  40. Giavazzi, R., Alessandri, G., Spreafico, F., Garattini, S. & Mantovani, A. Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br. J. Cancer 42, 462–472 (1980)
    Article CAS PubMed PubMed Central Google Scholar
  41. Wagner, M., Jonjic´, S., Koszinowski, U. H. & Messerle, M. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73, 7056–7060 (1999)
    Article CAS PubMed PubMed Central Google Scholar
  42. Jonjic´, S., Pavic´, I., Lucin, P., Rukavina, D. & Koszinowski, U. H. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 64, 5457–5464 (1990)
    Article PubMed PubMed Central Google Scholar
  43. Reddehase, M. J. et al. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55, 264–273 (1985)
    Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We thank N. Polentarutti, G. Benigni, M. Erreni, F. Colombo, V. Juranic´ Lisnic´ and D. Kvestak and Computational and Molecular Biology CRUK MI core facilities for technical assistance, M. Nebuloni for hepatocellular carcinoma histology, A. Doni for STED images, and F. Ficara, R. Carriero and D. Mavilio for discussions. The contributions of the European Commission (ERC project PHII-669415; FP7 project 281608 TIMER; ESA/ITN, H2020-MSCA-ITN-2015-676129), Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR) (project FIRB RBAP11H2R9), Associazione Italiana Ricerca sul Cancro (AIRC IG-19014 and AIRC 5x1000-9962), Fondazione CARIPLO (project 2015-0564), European Regional Development Fund (grant KK.01.1.1.01.0006, to S.J.) and the Italian Ministry of Health are gratefully acknowledged. M.M. received a European Federation of Immunological Sciences short-term fellowship to perform viral infection experiments in the laboratory of S.Jo.

Author information

Author notes

  1. Eduardo Bonavita
    Present address: Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4QL, UK
  2. Martina Molgora and Eduardo Bonavita: These authors contributed equally to this work.

Authors and Affiliations

  1. Humanitas Clinical and Research Center, Rozzano, 20089, Italy
    Martina Molgora, Eduardo Bonavita, Andrea Ponzetta, Marialuisa Barbagallo, Sébastien Jaillon, Elena Magrini, Francesca Gianni, Cecilia Garlanda & Alberto Mantovani
  2. Department of Animal Pathology, Faculty of Veterinary Medicine, University of Milan, Milan, 20133, Italy
    Federica Riva
  3. Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele Milan, Italy
    Sébastien Jaillon, Cecilia Garlanda & Alberto Mantovani
  4. Faculty of Medicine, University of Rijeka, Rijeka, 51000, Croatia
    Branka Popović & Stipan Jonjić
  5. Dipartimento di Medicina Molecolare Istituto Pasteur-Fondazione Cenci Bolognetti, Università di Roma “La Sapienza”, Rome, 00161, Italy
    Giovanni Bernardini & Angela Santoni
  6. IRCCS Neuromed, 86077 Pozzilli (IS), Italy
    Giovanni Bernardini & Angela Santoni
  7. Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4QL, UK
    Santiago Zelenay
  8. The William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK
    Alberto Mantovani

Authors

  1. Martina Molgora
  2. Eduardo Bonavita
  3. Andrea Ponzetta
  4. Federica Riva
  5. Marialuisa Barbagallo
  6. Sébastien Jaillon
  7. Branka Popović
  8. Giovanni Bernardini
  9. Elena Magrini
  10. Francesca Gianni
  11. Santiago Zelenay
  12. Stipan Jonjić
  13. Angela Santoni
  14. Cecilia Garlanda
  15. Alberto Mantovani

Contributions

E.B. and M.M. played a key role in designing and conducting most experiments and drafted the manuscript. F.R., M.B., F.G. and E.M. provided technological support in in vivo experiments. A.P., S.Ja., B.P. and G.B. contributed to the experimental design and in vivo experiments. S.Z. contributed to RNA-seq analysis. S.Jo. and A.S. contributed to the experimental design and supervision of the study. C.G. and A.M. contributed to the experimental design and supervision of the study, and suggested the role of IL-1R8 as a novel checkpoint inhibitor of NK cells.

Corresponding authors

Correspondence toCecilia Garlanda or Alberto Mantovani.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Additional information

Reviewer Information Nature thanks M. Karin, M. Smyth and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data figures and tables

Extended Data Figure 1 Expression of IL-1R8 in human and mouse NK cells.

a, b, IL1R8 mRNA expression in human primary NK cells, compared with T and B cells, neutrophils, monocytes and _in vitro_-derived macrophages (a) and in human primary NK cell maturation stages (CD56brCD16−, CD56brCD16+, CD56dimCD16+), and in the CD56dimCD16− subset (b). c, Representative FACS plot of human NK cell subsets and histograms of IL-1R8 expression in NK cell subsets. d, IL-1R8 protein expression in human bone marrow precursors and mature cells. e, ILR family member (Il1r1, Il1r2, Il1r3, Il1r4, Il1r5, Il1r6, Il1r8) mRNA expression in mouse primary NK cells isolated from the spleen. f, IL-1R8 protein expression in mouse NK cells by confocal microscopy. Scale bars, 10 μm. g, Representative FACS plot of mouse NK cell subsets. a, b, d, *P < 0.05, **P < 0.01, ***P < 0.001. One-way ANOVA. Mean ± s.e.m. a, n = 6 (NK and B cells) or n = 4 donors; b, n = 5 donors; d, n = 4 donors; e, n = 2 mice; f, representative images out of four collected per group. a, b, d–f, One experiment performed.

Extended Data Figure 2 Phenotypic analysis of Il1r8 −/− NK cells.

a, b, Representative plot of fluorescence-activated cell sorting of mouse NK cell subsets in Il1r8+/+ and Il1r8 −/− mice (a) and histograms of KLRG1 expression in NK cells (b). c, d, NK absolute number and NK cell subsets (DN, CD11blow, DP and CD27low) in bone marrow, spleen and blood of Il1r8+/+ and Il1r8 −/− newborn mice at 2 (c) and 3 (d) weeks of age. e, Frequency of bone marrow precursors in Il1r8+/+ and Il1r8 −/− mice. f, NKG2D, DNAM-1 and LY49H expression in peripheral NK cells and NK cell subsets of Il1r8+/+ and Il1r8 −/− mice. g, Frequency of splenic Perforin+ NK cell subsets upon stimulation in Il1r8+/+ and Il1r8 −/− mice. h, i, Peripheral NK cell absolute number (h) and CD27low NK cell frequency (i) in bone marrow chimaeric mice upon reconstitution (9 weeks). j, k, Peripheral NK cell (j) and NK cell subset (k) frequency in competitive chimaeric mice transplanted with 50% of Il1r8+/+ CD45.1 cells and 50% of Il1r8 −/− CD45.2 cells upon reconstitution (9 weeks). Upon reconstitution, a defective engraftment (12% instead of 50% engraftment) of Il1r8 −/− stem cells was observed in competitive conditions. l, IFNγ production by Il1r8+/+ and Il1r8 −/− NK cells upon co-culture with LPS- or CpG-primed Il1r8+/+ and Il1r8 −/− dendritic cells. c–l, *P < 0.05, **P < 0.01, ***P < 0.001 between selected relevant comparisons, two-tailed unpaired Student’s _t_-test. Centre values and error bars, mean ± s.e.m. At least five animals per group were used. c, d, Three pooled experiments; e–l, one experiment was performed.

Extended Data Figure 3 Mechanism of IL-1R8-dependent regulation of NK cells.

a, Splenic CD27low NK cell frequency in wild-type, Il1r8 −/−, Il18 −/− and Il18 −/−/Il1r8 −/− mice. b, Peripheral CD27low NK cell frequency in wild-type, Il1r8 −/−, Il1r1 −/− and Il1r8 −/− Il1r1 −/− mice (left) and IFNγ production by splenic NK cells after IL-12 and IL-1β or IL-18 stimulation (right). c, d, Splenic CD27low NK cell frequency in Il1r8+/+ and Il1r8 −/− mice upon commensal flora depletion (c) and breeding in co-housing conditions (d). e, STED microscopy of human NK cells stimulated with IL-18. Magnification bar, 2 μm. a–d, *P < 0.05, **P < 0.01, ***P < 0.001 between selected relevant comparisons, two-tailed unpaired Student’s _t_-test; Centre values and error bars, mean ± s.e.m. a, n = 3, 5, or 6 mice; at least five animals per group were used (b–d). a–d, One experiment was performed. e, Representative images out of three collected from two donors.

Extended Data Figure 4 RNA-seq analysis of Il1r8+/+ and Il1r8 −/− NK cells.

Metascape analysis of enriched gene pathways of resting and IL-18-activated Il1r8+/+ and Il1r8 −/− NK cells. See also Supplementary Table 1 and data deposited in the NCBI Gene Expression Omnibus under accession number GSE105043.

Extended Data Figure 5 NK-cell-mediated resistance to hepatocellular carcinoma and metastasis in IL-1R8-deficient mice.

a, Macroscopic score of liver lesions in female Il1r8+/+ and Il1r8 −/− mice 6, 10 and 12 months after diethylnitrosamine (DEN) injection. b, Incidence of hepatocellular carcinoma in Il1r8+/+ and Il1r8 −/− female and male mice. c, Frequency of IFNγ+ NK cells in spleen of Il1r8+/+ and Il1r8 −/− tumour-bearing mice. d, Macroscopic score of liver lesions in female Il1r8+/+ and Il1r8 −/− mice upon NK cell depletion. e, 2-Deoxyglucosone (2-DG) quantification in lungs of Il1r8+/+ and Il1r8 −/− tumour-bearing mice upon NK cell depletion. f, Primary tumour growth in Il1r8+/+ and Il1r8 −/− mice (25 days after MN/MCA1 cell line injection). g, Number of lung metastases in Il1r8+/+ and Il1r8 −/− MN/MCA1 sarcoma-bearing mice upon IFNγ or IL-18 neutralization. h, Volume of lung metastases in Il1r8+/+ and Il1r8 −/− MN/MCA1-bearing mice upon depletion of IL-17A or CD4+/CD8+ cells. i, Number of lung metastases in Il1r8+/+ and Il1r8 −/−, Il1r1 −/−, Il1r1 −/−/Il1r8 −/− MN/MCA1-bearing mice. j, Number of liver metastases in Il1r8+/+, Il1r8 −/−, Il18 −/−, Il18 −/− Il1r8 −/− MC38 colon carcinoma-bearing mice. k, Il1r8+/+ and Il1r8 −/− NK cell absolute number 3 or 7 days after adoptive transfer. l, In vivo Il1r8+/+ and Il1r8 −/− NK cell proliferation 3 days after adoptive transfer. m, Ex vivo IFNγ production and degranulation upon 4 h stimulation with PMA-ionomycin, IL-12 and IL-18 in adoptively transferred Il1r8+/+ and Il1r8 −/− NK cells. n, Volume of lung metastases in Il1r8+/+ MN/MCA1 sarcoma-bearing mice after adoptive transfer of Il1r8+/+ and Il1r8 −/− NK cells. a, c–e, g–j, m–n, *P < 0.05, **P < 0.01, ***P < 0.001 between selected relevant comparisons, two-tailed unpaired Student’s _t_-test or Mann–Whitney _U_-test. #P < 0.05, ##P < 0.01, Kruskal–Wallis and Dunn’s multiple comparison test. Centre values and error bars, mean ± s.e.m. a, n = 9, 10, 11, 18, 21 mice; b, n = 8–21 mice; c, n = 6 mice; d, n = 10, 12, 13 mice; e, n = 4 (Il1r8 −/− isotype) or n = 5; f, n = 10; g, n = 6, 7, 9, 10 mice; h, n = 5, 6, 12 mice; i, n = 6, 8, 10 mice; j, n = 4, 5, 7 mice; k, l, m, n = 3 mice; n, n = 9, 10, 12 mice. Representative experiment out of three (a, b), 2 (d), 6 (f), or one (c, e, g–n) experiments performed. NT, not treated.

Source data

Extended Data Figure 6 NK-cell-mediated anti-viral resistance in IL-1R8-deficient mice.

Cytokine serum levels in Il1r8+/+ and Il1r8 −/− infected mice (1.5 and 4.5 days after infection). *P < 0.05, **P < 0.01, ***P < 0.001, unpaired Student’s _t_-test. Centre values and error bars, mean ± s.e.m.; n = 5 mice. One experiment was performed.

Extended Data Table 1 Serum cytokine and liver enzyme levels in hepatocellular carcinoma-bearing mice

Full size table

Supplementary information

PowerPoint slides

Source data

Rights and permissions

About this article

Cite this article

Molgora, M., Bonavita, E., Ponzetta, A. et al. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity.Nature 551, 110–114 (2017). https://doi.org/10.1038/nature24293

Download citation